The STEP trials evaluated semaglutide and showed average weight reductions of around 15% over 68 weeks, while SURMOUNT trialsfocusing on tirzepatide, a dual GIP/GLP-1 receptor agonistdemonstrated even greater reductions, with participants losing up to 21% of their body weight over 72 weeks (Note: GIP = Glucose-dependent insulinotropic polypeptide)
Dentin hypersensitivity: pain mechanisms and aetiology of exposed cervical dentin
Its about being able to provide more comprehensive, integrated care for the patients I already see
Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation
Dozens of telehealth platforms now offer GLP-1 prescriptions, and the differences between them matter more than their marketing suggests
At ME Skin and Wellness, located within Elizalde Medspa, were proud to offer semaglutide, the revolutionary weight loss treatment thats changing lives